ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ORAGENICS, INC. (OGEN) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 747.46 thousand shares as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2024-11-13
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 747.46K shares.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 348.83K shares.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 298.96K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 261.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed |
|---|---|---|
| 2024-09-30 | 747.46K shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 348.83K shares 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 298.96K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 261.00K shares 10-Q · filed 2024-11-13 | |
| 2022-09-30 | 17.99M shares 10-Q/A · filed 2023-04-14 | |
| 2022-06-30 | 18.04M shares 10-Q/A · filed 2023-04-14 | |
| 2022-03-31 | 18.04M shares 10-Q/A · filed 2023-04-14 | |
| 2021-12-31 | 18.04M shares 10-Q/A · filed 2023-04-14 | |
| 2021-09-30 | 18.04M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 18.04M shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 18.04M shares 10-Q · filed 2021-05-03 | |
| 2020-12-31 | 20.51M shares 10-Q/A · filed 2023-04-14 | |
| 2020-09-30 | 20.51M shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 26.16M shares 10-Q · filed 2020-08-14 | |
| 2020-03-31 | 26.54M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 26.54M shares 10-Q · filed 2021-11-15 | |
| 2018-12-31 | 26.54M shares 10-Q · filed 2021-05-03 | 7.37M shares 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |